Stock listing

Biocryst Pharmaceuticals, Inc.

Selected listing: BO1 · MUN · EUR · DE

Biocryst Pharmaceuticals, Inc. (Munich:BO1), Health Technology. Latest release Oct 5, 2026: BioCryst Announces Formation of Scientific Advisory Board to Drive…

BO1:MUNEURDEUpdated September 25, 2026
Biocryst Pharmaceuticals, Inc. logo
Ticker
Munich:BO1
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
Munich
Currency
EUR

About Biocryst Pharmaceuticals, Inc.

Biocryst Pharmaceuticals, Inc. (BCRX) is a public company based in the United States, specializing in the development of innovative therapies for rare diseases. Biocryst focuses on creating treatments that address unmet medical needs, leveraging its expertise in biopharmaceuticals.

Latest news from Biocryst Pharmaceuticals, Inc.

All Biocryst Pharmaceuticals, Inc. news →

Events

Replays

  • BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 08:30 AM ET

    Watch
  • BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 08:30 AM ET

    Watch
  • BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 08:30 AM ET

    Watch

Research Biocryst Pharmaceuticals, Inc.

Alternate listings